Clinical laboratory assays for HER-2/neu amplification and overexpression: quality assurance, standardization, and proficiency testing.

@article{2002ClinicalLA,
  title={Clinical laboratory assays for HER-2/neu amplification and overexpression: quality assurance, standardization, and proficiency testing.},
  author={},
  journal={Archives of pathology & laboratory medicine},
  year={2002},
  volume={126 7},
  pages={803-8}
}
  • Published 2002 in Archives of pathology & laboratory medicine
OBJECTIVE To present and contrast the results of immunohistochemistry and fluorescence in situ hybridization (FISH) proficiency testing surveys for HER-2/neu, as conducted by the Cell Markers and Cytogenetics Committees of the College of American Pathologists. DESIGN During the past 2 years, unstained sections from invasive breast carcinomas have been used for both immunohistochemistry and interphase FISH proficiency surveys. In most instances, the same cases were used for both the Cell… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 17 extracted citations

Chromogenic in situ hybridization compared with other approaches to evaluate HER2/neu status in breast carcinomas

Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas • 2013

Potential utility of an expression array signature for predicting anthracycline responsiveness or resistance.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology • 2012

Similar Papers

Loading similar papers…